P Ravez

768 total citations
22 papers, 620 citations indexed

About

P Ravez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, P Ravez has authored 22 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in P Ravez's work include Lung Cancer Research Studies (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Lung Cancer Treatments and Mutations (5 papers). P Ravez is often cited by papers focused on Lung Cancer Research Studies (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Lung Cancer Treatments and Mutations (5 papers). P Ravez collaborates with scholars based in Belgium and France. P Ravez's co-authors include Jean Klášterský, P Libert, Jean‐Paul Sculier, G. Vandermoten, J Thiriaux, G. Bureau, G Dabouis, H. Lacroix, Michel Richez and P Rocmans and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

P Ravez

20 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Ravez Belgium 11 453 453 171 91 48 22 620
E. Quoix France 11 631 1.4× 292 0.6× 136 0.8× 86 0.9× 63 1.3× 43 847
Akira Motohiro Japan 14 331 0.7× 240 0.5× 88 0.5× 113 1.2× 91 1.9× 50 570
Tobias R. Overbeck Germany 14 234 0.5× 237 0.5× 141 0.8× 35 0.4× 80 1.7× 51 513
Ignazio Cataldo Italy 11 199 0.4× 225 0.5× 106 0.6× 117 1.3× 75 1.6× 48 443
Jennifer Kwak United States 13 174 0.4× 240 0.5× 57 0.3× 122 1.3× 95 2.0× 40 630
S. Krysa Germany 8 313 0.7× 192 0.4× 83 0.5× 82 0.9× 78 1.6× 17 403
Alfred E. Jones United States 10 223 0.5× 92 0.2× 59 0.3× 47 0.5× 46 1.0× 20 447
Tatsuo Nakano Japan 9 112 0.2× 220 0.5× 41 0.2× 98 1.1× 178 3.7× 46 426
Naoko Morishita Japan 14 400 0.9× 260 0.6× 63 0.4× 38 0.4× 61 1.3× 62 586
Daisuke Minami Japan 15 376 0.8× 316 0.7× 129 0.8× 32 0.4× 63 1.3× 54 581

Countries citing papers authored by P Ravez

Since Specialization
Citations

This map shows the geographic impact of P Ravez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Ravez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Ravez more than expected).

Fields of papers citing papers by P Ravez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Ravez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Ravez. The network helps show where P Ravez may publish in the future.

Co-authorship network of co-authors of P Ravez

This figure shows the co-authorship network connecting the top 25 collaborators of P Ravez. A scholar is included among the top collaborators of P Ravez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Ravez. P Ravez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravez, P, et al.. (2013). Paradoxical reaction in non HIV-tuberculosis, a rare case with pancreatic involvement. SHILAP Revista de lepidopterología. 96(4). 265–265. 2 indexed citations
2.
Klášterský, Jean, Jean‐Paul Sculier, H. Lacroix, et al.. (1990). A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.. Journal of Clinical Oncology. 8(9). 1556–1562. 198 indexed citations
3.
Sculier, Jean‐Paul, Jean Klášterský, P Libert, et al.. (1990). A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. Annals of Oncology. 1(2). 128–133. 18 indexed citations
4.
Body, J.J., J.P. Sculier, Marianne Paesmans, et al.. (1990). Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. Cancer. 65(7). 1552–1556. 51 indexed citations
5.
Klášterský, Jean, G Dabouis, G. Bureau, et al.. (1990). A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.. PubMed. 17(1 Suppl 2). 20–4. 3 indexed citations
6.
Klášterský, Jean, Jean‐Paul Sculier, G. Bureau, et al.. (1989). Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.. Journal of Clinical Oncology. 7(8). 1087–1092. 113 indexed citations
7.
Coffernils, M, et al.. (1989). [Sleep apnea syndrome and hypothyroidism: apropos of a new case and a review of the literature].. PubMed. 10(3). 89–93. 1 indexed citations
8.
Sculier, Jean‐Paul, Jean Klášterský, D. Becquart, et al.. (1988). Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer. European Journal of Cancer and Clinical Oncology. 24(3). 519–526. 10 indexed citations
9.
Sergysels, R, et al.. (1988). [Instrumentation support in respiratory kinesiotherapy].. PubMed. 5(5). 463–89. 1 indexed citations
10.
Sculier, Jean‐Paul, Jean Klášterský, G. Vandermoten, et al.. (1987). Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: A pilot study by the lung cancer working party (Belgium). Lung Cancer. 3(1). 50–50. 12 indexed citations
11.
Schrijen, F, et al.. (1987). Cardiovascular changes during isometric and dynamic exercise in chronic lung disease.. PubMed. 70(4). 199–204. 2 indexed citations
12.
Ravez, P, et al.. (1986). Effect of intermittent high-frequency intrapulmonary percussive breathing on mucus transport.. PubMed. 146. 285–9. 12 indexed citations
13.
Paiva, Manuel, Alain Van Muylem, P Ravez, & Jean Claude Yernault. (1986). Preinspiratory lung volume dependence of the slope of the alveolar plateau. Respiration Physiology. 63(3). 327–338. 20 indexed citations
14.
Klášterský, Jean, Jean‐Paul Sculier, P Ravez, et al.. (1986). A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.. Journal of Clinical Oncology. 4(12). 1780–1786. 117 indexed citations
15.
Ravez, P, et al.. (1985). TACTILE OROTRACHEAL INTUBATION. British Journal of Anaesthesia. 57(3). 356–356. 1 indexed citations
16.
Paiva, Manuel, Alain Van Muylem, P Ravez, & Jean Claude Yernault. (1984). Inspired volume dependence of the slope of the alveolar plateau. Respiration Physiology. 56(3). 309–325. 34 indexed citations
17.
Jc, Yernault, et al.. (1983). Effect of almitrine bismesylate on the distribution of ventilation and mechanics of breathing in patients with COLD.. PubMed. 126. 265–70. 2 indexed citations
18.
Jc, Yernault, et al.. (1982). Effect of almitrine on the mechanics of breathing in normal man.. PubMed. 18(4). 659–63. 3 indexed citations
19.
Ravez, P, et al.. (1981). [Spontaneous mediastinal emphysema. Report of two cases (author's transl)].. PubMed. 2(10). 961–3. 1 indexed citations
20.
Ravez, P, et al.. (1979). Left chylothorax complicating a translumbar aortography.. PubMed. 78(3). 169–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026